The Liver Meeting 2023-MASLD and Pediatric SIG: MAFLD from Tweens to Twenties -3092

MASLD and Pediatric SIG: MAFLD from Tweens to Twenties -3092

Video Transcription

Video Summary

In the video, experts discuss managing metabolic-associated liver diseases in young adults and pediatric populations, highlighting the importance of addressing metabolic challenges during the transition from adolescence to adulthood. They delve into genetic factors like PNPLA3 and emphasize the need for a comprehensive approach tailored to developmental stages, genetic influences, and sex-specific factors. Furthermore, the experts stress the significance of carefully transitioning pediatric patients with metabolic issues to adult care settings, emphasizing individualized transition plans, involving patients and families in decision-making, and considering factors such as genetics, lifestyle interventions, and social determinants of health. They advocate for a multidisciplinary approach, personalized treatment plans, and early interventions to optimize outcomes in pediatric and emerging adult populations.

Keywords

metabolic-associated liver diseases

young adults

pediatric populations

metabolic challenges

adolescence to adulthood transition

genetic factors

PNPLA3

comprehensive approach

developmental stages

sex-specific factors

transitioning pediatric patients

individualized transition plans